Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of ageJanet Rowan, William M. Hague, Elaine Rush et al.|BMJ Open Diabetes Research & Care|2018Cited by 295
Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetesTrecia A. Wouldes, Janet Rowan, Elaine Rush et al.|Archives of Disease in Childhood Fetal & Neonatal|2016Cited by 109
Maternal and Neonatal Circulating Markers of Metabolic and Cardiovascular Risk in the Metformin in Gestational Diabetes (MiG) TrialHelen L. Barrett, Janet Rowan, Candice M. Houda et al.|Diabetes Care|2012Cited by 51
Reduced Cortical Excitability, Neuroplasticity, and Salivary Cortisol in 11–13-Year-Old Children Born to Women with Gestational Diabetes MellitusJago M. Van Dam, Julia B. Pitcher, William M. Hague et al.|EBioMedicine|2018Cited by 40
Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trialMalcolm Battin, Janet Rowan, Elaine Rush et al.|BMC Pediatrics|2015Cited by 36